Vimarsana
Biggest News Aggregation in the World

Licensing Negotiations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Licensing Negotiations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Licensing Negotiations Today - Breaking & Trending Today

Current State and Emerging Challenges of SEP Licensing for Intelligent Connected Vehicles in China (I) | Linda Liu & Partners - Vimarsana News

Current State and Emerging Challenges of SEP Licensing for Intelligent Connected Vehicles in China (I) | Linda Liu & Partners

The new trends of motorization, intelligence, networking, and shared service of automobiles are leading to a global reform and becoming industrial technological highlands across the...

The Japan Patent Office's 'Guide to Licensing Negotiations' - Vimarsana News

The Japan Patent Office's 'Guide to Licensing Negotiations'

The office’s updated guide contains major changes, explains Takanori Abe of Abe & Partners.

Biden Administration Provides Guidance on Remedies for FRAND-Assured SEPs Levels the Playing Field against Big Tech and China | Kidon IP - Vimarsana News

Biden Administration Provides Guidance on Remedies for FRAND-Assured SEPs Levels the Playing Field against Big Tech and China | Kidon IP

In December 2021, only a few days after U.S. Department of Justice AAG for Antitrust Jonathan Kanter took office, and long before the USPTO and NIST had confirmed leadership in place,...

Trump-Era Standard Essential Patent Policy Removed - Vimarsana News

Trump-Era Standard Essential Patent Policy Removed

Courts have held that antitrust applies when patentees act beyond scope of patent. But determining where patent protection ends, antitrust scrutiny begins remains controversial. This tension arises today in the legal treatment of conduct involving Standard Essential Patents.

This week in IP: Coke chemist jailed, JPO invites SEP comments, and more - Vimarsana News

This week in IP: Coke chemist jailed, JPO invites SEP comments, and more

Peru adopts EPO system; Moderna says sue government; Appian awarded $2bn in trade secrets case; US senator threatens Disney copyright; Vidal announces examiner training; USPTO reveals pro bono awards